4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tianda Pharmaceuticals Limited (0455) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Central, Hong Kong with about 613 employees. Its market capitalization is roughly HKD 221 million. In the fiscal year ended 2025-12-31, 0455 reported HKD 323M in revenue and (HKD 70M) in net income.
Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Revenue | HKD 323M | HKD 330M | HKD 532M | HKD 510M |
| Gross Profit | HKD 133M | HKD 152M | HKD 256M | HKD 241M |
| Operating Income (EBIT) | (HKD 52M) | (HKD 50M) | (HKD 24M) | (HKD 42M) |
| Net Income | (HKD 70M) | (HKD 61M) | (HKD 24M) | (HKD 20M) |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-03-31 |
|---|---|---|---|---|
| Dividends Paid | — | (HKD 6M) | (HKD 6M) | (HKD 9M) |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | HKD 748M | HKD 765M | HKD 917M | HKD 1.1B | — |
| Total Liabilities | HKD 292M | HKD 259M | HKD 325M | HKD 434M | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0455 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms